SIRT2 Antibodies

Santa Cruz Biotechnology offers a broad range of SIRT2 monoclonal antibodies for advanced research in cellular regulation and metabolism. SIRT2 monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SIRT2, a member of the sirtuin family, plays a crucial role in regulating cellular processes such as cell cycle progression, metabolism, and stress response. The deacetylase activity of SIRT2 is essential for maintaining cellular homeostasis and has been implicated in various diseases, including cancer and neurodegenerative disorders. Understanding SIRT2 function is vital for developing therapeutic strategies targeting these conditions. Researchers worldwide utilize SIRT2 monoclonal antibodies to investigate cellular pathways and molecular mechanisms. Current studies focus on how SIRT2 influences cell cycle regulation and metabolic processes. Ongoing research explores SIRT2's potential as a therapeutic target in various disease models. Santa Cruz Biotechnology SIRT2 monoclonal antibodies enable researchers to advance scientific understanding and contribute to potential breakthrough treatments in cancer and neurodegenerative diseases.